| Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome. | |
| | |
MedLine Citation:
|
PMID: 17655517 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Linezolid is an oxazolidinone antibacterial agent indicated for serious gram-positive infections. Only minor adverse effects were seen in phase III trials. However, more serious adverse effects were reported after commercial release, including cases of lactic acidosis, peripheral and optic neuropathy, and serotonin syndrome. Peripheral and optic neuropathy was usually seen after several months of linezolid therapy (median 5 mo), lactic acidosis after several weeks (median 6 wks), and serotonin syndrome after several days (median 4 days). Death occurred in two of seven reported cases of lactic acidosis, and three of 15 reported cases of serotonin syndrome. Improvement or complete recovery occurred in all cases of optic neuropathy, whereas complete recovery failed to occur in any patient with peripheral neuropathy. Linezolid should be discontinued immediately in patients experiencing these adverse effects. Patients receiving linezolid for more than 28 days should be monitored for signs of peripheral and optic neuropathy. |
| | |
Authors:
|
Masashi Narita; Brian T Tsuji; Victor L Yu |
Related Documents
:
|
2644317 - Cutaneous effects and therapeutic uses of heat with emphasis on infrared radiation. 12890207 - An evaluation of the usefulness of mycophenolate mofetil in pemphigus. 9242897 - Use of risperidone in delirium: case reports. 12609397 - Topiramate overdose: a case report and literature review. 23449377 - Meningitis due to bacillus cereus: a case report and review of the literature. 7992117 - Case report 858: postradiation osteosarcoma of the patella. |
Publication Detail:
|
Type: Case Reports; Journal Article; Review |
Journal Detail:
|
Title: Pharmacotherapy Volume: 27 ISSN: 0277-0008 ISO Abbreviation: Pharmacotherapy Publication Date: 2007 Aug |
Date Detail:
|
Created Date: 2007-07-27 Completed Date: 2007-10-11 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8111305 Medline TA: Pharmacotherapy Country: United States |
Other Details:
|
Languages: eng Pagination: 1189-97 Citation Subset: IM |
Affiliation:
|
Infectious Disease Section, University of Pittsburgh, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania 15240, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetamides
/
administration & dosage,
adverse effects* Acidosis, Lactic / chemically induced*, physiopathology Anti-Infective Agents / administration & dosage, adverse effects* Drug Interactions Female Humans Male Optic Nerve Diseases / chemically induced*, physiopathology Oxazolidinones / administration & dosage, adverse effects* Peripheral Nervous System Diseases / chemically induced*, physiopathology Risk Factors Serotonin Syndrome / chemically induced, physiopathology Serotonin Uptake Inhibitors / adverse effects |
| Chemical | |
Reg. No./Substance:
|
0/Acetamides; 0/Anti-Infective Agents; 0/Oxazolidinones; 0/Serotonin Uptake Inhibitors; 165800-03-3/linezolid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Sugammadex: a novel agent for the reversal of neuromuscular blockade.
Next Document: Rapid development of Acinetobacter baumannii resistance to tigecycline.